Global Medical Marijuana Market Expected to Reach XX Million by 2025
According to a new report published by Reports Monitor titled, “Medical Marijuana Market by Type, Property & Applications: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the Medical Marijuana Market was valued at XX million in 2016 and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025. North America is considered to be the leading region owing to the increasing number of U.S states, legalizing the use of marijuana in the medical applications.
Medical marijuana is also referred to as medical cannabis. It is an herbal drug derived from plants of the genus cannabis. It is mostly used for the treatment of specific symptom or disease. However, medical marijuana is mainly used to treat pain, nausea, muscle spasms, anxiety, sleep problems, and others.
The market is driven by increasing interest among the academic researchers and healthcare providers regarding the therapeutic uses of marijuana is one of the significant element for the growth of the market. Moreover, researchers have stated that marijuana is very effective in providing relief to the patient suffering from HIV/AIDS, glaucoma, cancer, and multiple sclerosis. The increasing number of therapeutic applications of the drug is major factor responsible for propelling the market growth.
The global medical marijuana market report consists of various tools and techniques including, porters, value chain, market share analysis, and others. The data used in this report is gathered from extensive primary and secondary sources. These report gives the overall idea of market trends, opportunities, restraints, challenges, and others. The report includes major players along with their development strategies such as expansion, acquisition, merger, and others.
The market is segmented into various segments such as by type, by medical application, by chemical derivatives, by end-user, and by region. Based on the type of market it is mostly differentiated into sativa, indica, and hybrid. On the basis of medical application, the market is bifurcated into glaucoma, inflammatory bowel diseases, chronic pain, migraine, arthritis, anxiety, insomnia, AIDS, and others. According to the chemical derivatives, the market is split into THC(delta-9-tetrahydrocannabinol), CBD (cannabidiol) CBD capsules, CBD tincture or liquids, and CBD topical and hybrid (combination of THC & CBD). On the basis of end-user segment, the market is divided into pharmaceutical industry, hospital, research & development centers, and pharmacy stores.
Key Question Answered: •What will be the market size in 2025 and at what rate it will grow? •Who are the major key players in global medical marijuana market and what are their strategies? •Which vertical industry is expected to show major growth? •What segment and region will lead the market and why?
The major companies profiled in the report include: Cara Therapeutics Inc. Cannabis Sativa Inc. CannaGrow Holdings Inc. United Cannabis Corporation, Growblox Sciences Inc. GreenGro Technologies Inc. GW Pharmaceuticals plc, International Consolidated Companies Inc., and Lexaria Corp.
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.